Terms: = Breast cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Clinical Outcome
4 results:
1. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis.
Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C
Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772
[TBL] [Abstract] [Full Text] [Related]
2. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven rac1 Activation and breast cancer Cell Motility via Hypoxia-Inducible Factor 1α.
Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
[TBL] [Abstract] [Full Text] [Related]
3. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
[TBL] [Abstract] [Full Text] [Related]
4. p130Cas is an essential transducer element in ErbB2 transformation.
Cabodi S; Tinnirello A; Bisaro B; Tornillo G; del Pilar Camacho-Leal M; Forni G; Cojoca R; Iezzi M; Amici A; Montani M; Eva A; Di Stefano P; Muthuswamy SK; Tarone G; Turco E; Defilippi P
FASEB J; 2010 Oct; 24(10):3796-808. PubMed ID: 20505116
[TBL] [Abstract] [Full Text] [Related]